U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263191) titled 'A Study of Olanzapine in Participants With Bipolar Disorder.' on Nov. 23.
Brief Summary: This study aimed to identify treatment patterns in patients with bipolar disorder receiving olanzapine according to demographic and clinical characteristics and to evaluate the effectiveness of education on weight gain, a side effect of olanzapine, in preventing weight gain.
Study Start Date: Oct. 30
Study Type: OBSERVATIONAL
Condition:
Bipolar Disorder
Intervention:
DRUG: Olanzapine
As this is a non-interventional study designed to collect data as part of routine clinical practice, the selection and dosage of medication, treatment period,...